Envestnet Asset Management Inc Mesoblast LTD Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
BUY
$2.73 - $3.7 $35,364 - $47,929
12,954 Added 99.23%
26,008 $75,000
Q3 2022

Nov 10, 2022
BUY
$0.48 - $3.48 $6,265 - $45,427
13,054 New
13,054 $33,000

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email